Article Text

Download PDFPDF
CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma
  1. R Melki1,2,
  2. E Colomb1,
  3. N Lefort1,
  4. A P Brézin3,
  5. H-J Garchon1
  1. 1INSERM U580, Hôpital Necker, Paris, France
  2. 2Laboratoire de Biologie Cellulaire et Moléculaire, Université Ibnou Zohr, Agadir, Morocco
  3. 3Ophthalmology Unit, C.H.U. Cochin, Paris, France
  1. Correspondence to:
 H-J Garchon
 INSERM U580, Hôpital Necker, 161 rue de Sèvres, 75743 Paris, Cedex 15, France; garchonnecker.fr

Abstract

Introduction: Primary open-angle glaucoma (POAG) is a leading cause of visual impairment worldwide and a complex genetic disorder that affects mostly adults. Mutations in the MYOCILIN (MYOC) and OPTINEURIN genes account for rare forms with a Mendelian inheritance and for <5% of all POAG cases. The CYP1B1 gene, a member of the cytochrome P450 gene family, is a major cause of primary congenital glaucoma (PCG), a rare and severely blinding disease with recessive inheritance. However, CYP1B1 mutations have also been associated with cases of juvenile-onset glaucoma in some PCG families or shown to modify the age of onset of glaucoma linked to a MYOC mutation in a large family.

Objective: To investigate the role of CYP1B1 mutations in POAG predisposition, irrespective of the presence of a MYOC mutation.

Methods and subjects:CYP1B1 coding region variation was characterised by denaturing high performance liquid chromatography (DHPLC) and sequencing in 236 unrelated French Caucasian POAG patients and 47 population-matched controls.

Results: Eleven (4.6%) patients carried one or two mutated CYP1B1 gene(s) and no MYOC mutation. They showed juvenile or middle-age onset of disease (median age at diagnosis, 40 years, range 13–52), significantly earlier than in non-carrier patients. Apart from one, all mutations detected in POAG patients were previously associated with PCG.

Conclusion:CYP1B1 mutations might pose a significant risk for early-onset POAG and might also modify glaucoma phenotype in patients who do not carry a MYOC mutation.

  • DHPLC, denaturing high performance liquid chromatography
  • DMSO, dimethylsulfoxide
  • IOP, intraocular pressure
  • PCG, primary congenital glaucoma
  • POAG, primary open-angle glaucoma
  • TEAA, triethylammonium acetate
  • CYP1B1
  • genetics
  • glaucoma
  • mutation
  • screening

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • This work was supported by INSERM (Institut National de la Santé et de la Recherche Médicale), by the Assistance Publique des Hôpitaux de Paris (grant DRRC-AOM96110), by the Fondation pour la Recherche Médicale, and by Insite Vision Inc. (Alameda, CA). RM was awarded a fellowship of the Comite Mixte Inter-Universitaire Franco Marocain (AI 237/SVS/2000).

  • Conflict of interest: none declared.